Thus, we tested the levels of inflammatory factors in dl-NBP-administered mice and observed that AD mice treated with dl-NBP exhibited lower protein levels of IL-1β, TNF-α, and GFAP, compared with vehicle-treated AD mice. The gene discussed is GFAP; the disease is Alzheimer disease.